Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Gtx Inc patents


Recent patent applications related to Gtx Inc. Gtx Inc is listed as an Agent/Assignee. Note: Gtx Inc may have other listings under different names/spellings. We're not affiliated with Gtx Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "G" | Gtx Inc-related inventors


Methods of treating urological disorders using sarms

The present invention is directed to methods of treating, preventing, suppressing and/or inhibiting urological disorders such as urinary incontinence including stress urinary incontinence and pelvic floor disorders by administering a sarm compound of the invention.. . ... Gtx Inc

System and method for embedding a tracking device in a footwear insole

A novel tracking system is disclosed. In one embodiment, a long-range tracking device is incorporated into a removable footwear insole and a short-range tracking device is incorporated into another removable footwear insole. ... Gtx Inc

Compounds for treatment of cancer

The present invention relates to a compound of formula xxii and a compound of formula 17ya, which are defined as anywhere in the specification, to a composition comprising the same, and to a method of using thereof in the treatment of various forms of cancer.. . ... Gtx Inc

Solid forms of selective androgen receptor modulators

The present invention relates to solid forms of (s)—n-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide and process for producing the same.. . ... Gtx Inc

Method of treating her2-positive breast cancers with selective androgen receptor modulators (sarms)

This invention relates to the treatment of breast cancer in a subject, for example a female subject. Including methods of: treating metastatic breast cancer; refractory breast cancer; ar-positive breast cancer; ar-positive refractory breast cancer; ar-positive metastatic breast cancer; ar-positive and er-positive breast cancer; triple negative breast cancer; advanced breast cancer; breast cancer that has failed serm (tamoxifen, toremifene), aromatase inhibitor, palbociclib (ibrance), trastuzumab (herceptin, ado-trastuzumab emtansine), pertuzumab (perjeta), lapatinib, exemestane (aromasin), bevacizumab (avastin), and/or fulvestrant treatments; metastasis in a subject suffering from breast cancer; and/or her2-positive; comprising administering to the subject a therapeutically effective amount of a selective androgen receptor modulator (sarm) compound.. ... Gtx Inc

Emergency service provider monitoring and rehabilitation methods and devices

Systems and methods for simultaneously tracking physical conditions of multiple people during an event are disclosed. The system comprises at least one vital sign data collection device, a central processing unit compiling the collected vital sign data, and software executing on the central processing unit. ... Gtx Inc

Autonomous critical care systems and integrated combat casualty care systems

Systems, devices, and methods for monitoring and treating a patient on route to a medical facility are disclosed. The system comprises a critical care unit; at least one patient monitoring device coupled to the critical care unit, wherein the critical care unit obtains physiological data about the patient from each patient monitoring device; at least one patient treatment device coupled to the critical care unit, wherein the critical care unit provides treatment instructions to each patient treatment device; a two way communications device coupled to the critical care unit; and a remote communications terminal in communication with the two way communications device. ... Gtx Inc

Unified publishing platform

A unified publishing platform (upp) system is disclosed that may process electronic content to identify content data irrespective of the format of the electronic content. Content data may be separated from formatting to generate electronic content with different formats. ... Gtx Inc

Nuclear receptor binding agents

The present application relates to methods of treating, preventing, delaying the onset of, reducing the incidence of, or reducing the severity of fibrosis, obesity and conditions associated with post-menopausal obesity.. . ... Gtx Inc

Method of treating her2-positive breast cancers with selective androgen receptor modulators (sarms)

This invention relates to the treatment of breast cancer in a subject, for example a female subject. Including methods of: treating metastatic breast cancer; refractory breast cancer; ar-positive breast cancer; ar-positive refractory breast cancer; ar-positive metastatic breast cancer; ar-positive and er-positive breast cancer; triple negative breast cancer; advanced breast cancer; breast cancer that has failed serm (tamoxifen, toremifene), aromatase inhibitor, palbociclib (ibrance), trastuzumab (herceptin, ado-trastuzumab emtansine), pertuzumab (perjeta), lapatinib, exemestane (aromasin), bevacizumab (avastin), and/or fulvestrant treatments; metastasis in a subject suffering from breast cancer; and/or her2-positive; comprising administering to the subject a therapeutically effective amount of a selective androgen receptor modulator (sarm) compound.. ... Gtx Inc








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Gtx Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Gtx Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###